Key result
3-session behavioral lifestyle program proves feasible and boosts 30-day self-efficacy vs usual care in stable CAD.
Why the study?
Research on lifestyle programs for patients with coronary artery disease has largely recruited from hospitals or following acute coronary syndrome, leaving outpatient programs for stable disease less evaluated.
Does a 3-session behavioral health lifestyle program improve self-efficacy in patients with stable CAD treated in an outpatient cardiology clinic?
RCT (n=33)
Does a 3-session behavioral health lifestyle program improve self-efficacy in patients with stable CAD treated in an outpatient cardiology clinic?
A brief 3-session behavioral health program is feasible, acceptable, and effectively improves self-efficacy in outpatients with stable CAD.
Supports brief behavioral programs to enhance self-efficacy in stable CAD outpatients; extends RCT evidence for feasible lifestyle interventions in cardiology clinics.
Research on lifestyle programs for patients with coronary artery disease (CAD) has largely recruited from hospitals and/or recruited following acute coronary syndrome. By contrast, this study evaluated a 3-session behavioral health program for patients with stable CAD treated in an outpatient cardiology clinic. Thirty-three patients were randomized to the behavioral lifestyle intervention or to Treatment as Usual (TAU). A priori feasibility and acceptability criteria were met, and reliable change analyses revealed that at post-treatment and 30-day follow-up, significantly more intervention participants than TAU participants exhibited increased self-efficacy compared with baseline.
No takes yet. Share an insight, caveat, or question.
Wiener et al. (2020) conducted an RCT in Stable coronary artery disease (CAD) (n=33). Behavioral health lifestyle program vs. Treatment as Usual (TAU) was evaluated on Feasibility, acceptability, and increased self-efficacy. A 3-session behavioral health lifestyle program for outpatients with stable CAD met feasibility criteria and significantly increased self-efficacy at 30 days compared to treatment as usual.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: